After a rough pullback, the major indices are attempting to rebound higher. Helping, not only is Bitcoin starting to rebound, but so are down but not out tech stocks. Plus, markets are…
Live Updates With winter blast, keep an eye on natural gas stocks9:04am ETWith a chunk of the U.S. preparing for significant snow, keep an eye on natural gas stocks. For one, according…
Alphabet (NASDAQ:GOOG | GOOG Price Prediction)(NASDAQ:GOOGL) dominates the search engine market with a greater than 90% share, powering billions of daily queries through Google Search. Yet its growth extends beyond that core…
Shares of Novo Nordisk A/S (NYSE: NVO | NVO Price Prediction) dropped 1.9%today, closing at $48.25, just a whisker above the 52-week low of $45.05. Sometimes we see a divergence in share…
Markets are coming back strong. All thanks to the news that the government shutdown may soon be over, which would remove a good deal of uncertainty in the markets. In fact, in…
Pre-Market Stock Futures: The futures are trading higher as the new week begins, with most investors and traders relieved that last week has come to a close. Hopes that an end to…
The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that also tackle related conditions like diabetes and heart disease. Valued at over…
Eli Lilly (NYSE: LLY | LLY Price Prediction) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded expectations while raising full-year guidance. The stock traded at $854.08 following the…
Joel South The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and diabetes treatments into massive revenue streams for Novo Nordisk (NYSE:NVO | NVO Price Prediction) and Eli…
Friday’s market meltdown laid bare the vulnerabilities of the S&P 500. The index plunged 2.7%, erasing weekly gains amid President Trump’s threat of massive new tariffs on Chinese imports. This sharp drop…
Starting today, the U.S. imposed 100% tariffs on imports of branded or patented pharmaceutical products that President Trump announced last week. This sweeping measure targets foreign-made drugs to push manufacturers toward U.S.…
Insider buying is one of the few market signals that does not hide behind algorithms or price targets. When a director pulls out a personal checkbook and adds to his stake while…
Healthcare investing has felt like walking through quicksand this year. One moment, the sector looks ready to spring forward on breakthrough drugs and aging demographics, the next, it is yanked back by…
These five blue-chip giants remain Wall Street favorites and are outstanding ideas for long-term growth and income investors.
Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable insights. Known for his high-energy delivery and colorful metaphors, Cramer blends deep market…
